Any damage or defect in any one of the four heart valves can lead to a form of valve regurgitation disorders.
Valve Regurgitation Diagnostic and Treatment Market: Snapshot
Any damage or defect in any one of the four heart valves can lead to a form of valve regurgitation disorders. Leakage or regurgitation in any of the heart’s valves, known as mitral, tricuspid, aortic, and pulmonary, can lead to severe disturbances in the human body and cardiac systems. This highlights the need for efficient and rapid testing equipment in the global valve regurgitation diagnostic and treatment market. Another factor stimulating the growth in the industry is the rising evolution and adoption of advanced cardiac surgical procedures for adult patients. Disorders relating to dysfunction or leakage of the heart valves can be treated by medications as well as surgeries in the global valve regurgitation diagnostic and treatment market.
Increasing preference for minimally invasive surgeries and endovascular and transcatheter valve therapies is also expected to bolster the growing global valve regurgitation diagnostic and treatment market in coming years. However, risky and highly sensitive nature of various heart surgeries and dearth of highly skilled and specifically specialized heart surgeons can impede the growth of the global valve regurgitation diagnostic and treatment market in years to come. Some of the key factors propelling the need for efficient and precise diagnostic and therapeutic solutions in the global valve regurgitation diagnostic and treatment market include rapidly changing and increasingly sedentary nature of modern lifestyles, increased levels of stress, and rising consumption of alcohol, all of which are some of the key causes for heart diseases.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=58896
Valve regurgitation is a structural heart disease. Regurgitation is the name for leaking heart valves. It happens when a heart's valve does not close tightly. In patients with valve regurgitation, blood cannot move properly in the rest of the body. Valve regurgitation can be caused by problems with the heart valve such as damaged tissue cords, rheumatic fever, abnormality of the heart muscle, congenital heart defects, radiation therapy, and atrial fibrillation. Some common symptoms associated with valve regurgitation are abnormal heart sound, fatigue, swollen feet or ankles, and shortness of breath (dyspnea). Major complications associated with valve regurgitation are atrial fibrillation, heart failure, and pulmonary hypertension. Several factors can increase the risk of valve regurgitation, including a history of mitral valve prolapse or mitral valve stenosis, heart attacks, and infections such as endocarditis or rheumatic fever.
Doctors can diagnose valve regurgitation based on medical history and tests. The common diagnostic tests for the condition are echocardiogram, chest X-ray, cardiac MRI, and cardiac catheterization. An electrocardiogram (ECG) can be used to detect enlarged chambers of the heart due to valve regurgitation.
Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=58896
A rise in the prevalence of valve regurgitation is anticipated to drive the global valve regurgitation diagnostic and treatment market during the forecast period. Increase in government prioritization of valve regurgitation treatment is also expected to propel the global valve regurgitation diagnostic and treatment market in the near future. However, a shortage of health care experts in cardiology in Latin America and Middle East & Africa is likely to hamper the valve regurgitation diagnostic and treatment market in these regions. Favorable reimbursement health care policy in North America and Europe are anticipated to propel the market in these regions during the forecast period.
The global valve regurgitation diagnostic and treatment market can be segmented based on type of regurgitation, diagnostic test, treatment procedure, end-user, and region. In terms of type of regurgitation, the valve regurgitation diagnostic and treatment market can be divided into mitral regurgitation, aortic valve regurgitation, pulmonary or pulmonic regurgitation, and tricuspid regurgitation. Based on treatment, the valve regurgitation diagnostic and treatment market can be classified into surgical repair treatment and replacement treatment. In terms of diagnosis, the market can be divided into echocardiogram, chest X-ray, cardiac MRI, cardiac catheterization, and others. Based on end-user, the global valve regurgitation diagnostic and treatment market can be categorized into hospitals, special clinics, and academic institutes & research organization. The hospitals segment held a significant share of the market in 2017.
Pre Book Valve Regurgitation Diagnostic and Treatment Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=58896<ype=S
Based on region, the global valve regurgitation diagnostic and treatment market can be segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America accounted for a major share of the global market in 2017, followed by Europe and Asia Pacific. The U.S. held a significant share of the market in North America in terms of revenue in 2017. The valve regurgitation diagnostic and treatment market in Asia Pacific is expanding rapidly, due to an increase in the number of patients suffering from valve regurgitation. Better health care infrastructure, economic growth, rise in the number of insurance payers, expanding & developing private health care sector, and increase in awareness among people about valve regurgitation diagnosis and treatment are expected to propel the market in the region in the next few years. The valve regurgitation diagnostic and treatment market in Latin America and Middle East & Africa is projected to expand at a moderate growth rate from 2018 to 2026.
Key players operating in the global valve regurgitation diagnostic and treatment market include Abbott, Boston Scientific Corporation, Braile Biomédica, CryoLife, Inc., Edwards Lifesciences Corporation, LivaNova plc, Lepu Medical Technology, Medtronic, Micro Interventional Devices, Inc., and TTK HealthCare.
Browse more Reports by Transparency Market Research:
Non-vascular Stents Market: The market for global non-vascular stents is projected to be driven by the high incidence rates of luminal strictures across the globe. Metallic stents are most commonly used for the palliation of malignant cancerous disease in & airway tract due to its high durability and radial strength.
Hereditary Angioedema Market: It is projected that the global market for hereditary angioedema will see a rise of several new and emerging players in the next few years of the projection period. The competitive landscape of the market is a consolidated one because of the presence of only handful of leading players.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/